Smoking Cessation after Surgery and Mid-Term Outcomes of Surgical Revascularization.
Although multiple studies reported the devastating effect of Cigarette smoking (CS) on short-term outcomes of patients who underwent coronary artery bypass grafting surgery (CABG), its effect on long-term outcomes is still questionable. We aimed to evaluate the long-term outcomes of CS cessation after CABG surgery. This retrospective cohort study included all patients who underwent isolated CABG at our center between 2007 and 2016 and were either cigarette smoker just prior or at the time of surgery. Patients were stratified into those who continued CS and those who were persistently CS abstinent after CABG. The endpoints of the study were 5-year mortality and 5-year major adverse cardio- cerebrovascular events . Of a total of 28,945 patients who underwent isolated CABG, 9,173 current-cigarette smoker patients (93.5% males, mean age of 58.6 years) met our selection criteria and were included in the final analysis. Of these, 3302 patients (40.0%) continued CS after surgery and 5688 patients were persistently abstinent. Multivariable survival analysis demonstrated that CS cessation after CABG adjusted for major coronary risk factors, could reduce the 5-year mortality by 35% (HR=0.65, 95% CI: 0.54 - 0.77, p < 0.001), and the 5-year major adverse cardio-cerebrovascular events by 18% (HR=0.82, 95% CI: 0.74 - 0.92, p = 0.001). Our study shows that CS abstinence after CABG significantly reduces the long-term mortality and the number of major adverse events. As a result, patients who smoke should be encouraged to participate in CS cessation programs after CABG surgery.